The review essay by Donald Light about a Congressional Budget Office report on pharmaceutical research and development (R&D) (7) contains factual errors, leaves the reader uninformed about rebuttal responses to criticisms made in the review about studies of R&D costs, and draws erroneous conclusions about the nature of industry economics.

You do not currently have access to this content.